BU — Burcon NutraScience Cashflow Statement
0.000.00%
Last trade - 00:00- CA$16.25m
- CA$44.33m
- CA$2.26m
Annual cashflow statement for Burcon NutraScience, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -10.3 | -25.4 | -7.45 | -8.26 | -14.3 |
| Depreciation | |||||
| Amortisation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 4.63 | 19 | 1.39 | 1.85 | 8 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.547 | -0.357 | -0.425 | 0.068 | -4.13 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -5.91 | -6.02 | -5.78 | -5.51 | -9.16 |
| Capital Expenditures | -0.052 | -0.36 | -0.127 | -0.303 | -0.957 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -1.18 | -4.07 | 0.088 | -1.36 | 0.073 |
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1.23 | -4.43 | -0.039 | -1.66 | -0.883 |
| Financing Cash Flow Items | 0 | -0.09 | -0.107 | -0.236 | -0.133 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.174 | 4.9 | 8.56 | 10.2 | 3.85 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -6.97 | -5.54 | 2.74 | 3.08 | -6.33 |